Miran Rada

888 total citations
25 papers, 612 citations indexed

About

Miran Rada is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Miran Rada has authored 25 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Miran Rada's work include Cancer, Hypoxia, and Metabolism (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Miran Rada is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Miran Rada collaborates with scholars based in Canada, United Kingdom and United States. Miran Rada's co-authors include Salvador Macip, Dong‐Joo Cheon, Nickolai A. Barlev, Anthoula Lazaris, Peter Metrakos, Stephanie Petrillo, Jennifer Cha, Sandra Oršulić, Sameera Nallanthighal and Megan E. Kizer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Cancer Research.

In The Last Decade

Miran Rada

25 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miran Rada Canada 14 363 175 162 109 78 25 612
Jenny Paupert Belgium 15 311 0.9× 146 0.8× 313 1.9× 81 0.7× 43 0.6× 23 683
Aaron M. LeBeau United States 9 225 0.6× 124 0.7× 314 1.9× 119 1.1× 62 0.8× 12 517
Thale Kristin Olsen Sweden 11 335 0.9× 169 1.0× 144 0.9× 90 0.8× 54 0.7× 24 603
Érika Cosset Switzerland 12 289 0.8× 128 0.7× 122 0.8× 111 1.0× 35 0.4× 24 526
Lele Zhang China 6 231 0.6× 111 0.6× 244 1.5× 132 1.2× 143 1.8× 13 632
Michael Faibish United States 8 532 1.5× 124 0.7× 220 1.4× 187 1.7× 34 0.4× 10 701
Mark F. Santos United States 10 488 1.3× 305 1.7× 70 0.4× 108 1.0× 78 1.0× 23 612
François Kuonen Switzerland 17 298 0.8× 148 0.8× 287 1.8× 171 1.6× 45 0.6× 42 712
Neel I. Nissen Denmark 11 202 0.6× 132 0.8× 280 1.7× 89 0.8× 70 0.9× 18 600
Kiek Verrijp Netherlands 12 380 1.0× 162 0.9× 195 1.2× 210 1.9× 41 0.5× 15 774

Countries citing papers authored by Miran Rada

Since Specialization
Citations

This map shows the geographic impact of Miran Rada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miran Rada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miran Rada more than expected).

Fields of papers citing papers by Miran Rada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miran Rada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miran Rada. The network helps show where Miran Rada may publish in the future.

Co-authorship network of co-authors of Miran Rada

This figure shows the co-authorship network connecting the top 25 collaborators of Miran Rada. A scholar is included among the top collaborators of Miran Rada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miran Rada. Miran Rada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rada, Miran, et al.. (2025). Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications. Molecular and Cellular Biochemistry. 480(9). 4941–4959. 1 indexed citations
2.
Rada, Miran, et al.. (2025). Bruton’s Tyrosine Kinase: A Double-Edged Sword in Cancer and Aging. SHILAP Revista de lepidopterología. 3(2). 10–10. 1 indexed citations
3.
Rada, Miran, et al.. (2023). A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases. Biomedicines. 11(3). 731–731. 6 indexed citations
4.
Rada, Miran, Stephanie Petrillo, Andrew R. Reynolds, et al.. (2023). Abstract 1741: Inhibition of pcsk9 impairs the development of vessel co-option and potentiates anti-angiogenic therapy in colorectal cancer liver metastases. Cancer Research. 83(7_Supplement). 1741–1741. 1 indexed citations
5.
Rada, Miran, et al.. (2022). The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases. Frontiers in Oncology. 12. 1004793–1004793. 9 indexed citations
6.
Rada, Miran, et al.. (2022). Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3. Cancers. 14(10). 2540–2540. 11 indexed citations
7.
Rada, Miran, Stephanie Petrillo, Sébastien Tabariès, et al.. (2021). Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Communications Biology. 4(1). 950–950. 40 indexed citations
8.
Rada, Miran, et al.. (2020). Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model. Seminars in Cancer Biology. 71. 52–64. 36 indexed citations
9.
Nallanthighal, Sameera, Miran Rada, James Patrick Heiserman, et al.. (2020). Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer. Cell Death and Disease. 11(4). 258–258. 64 indexed citations
10.
Kim, Diane, et al.. (2020). Abstract 3331: Role of innate immune cells in the development of vessel co-opting CRC liver metastases. Cancer Research. 80(16_Supplement). 3331–3331. 2 indexed citations
11.
Lazaris, Anthoula, Miran Rada, Stephanie Petrillo, et al.. (2019). Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM). Cancers. 12(1). 35–35. 19 indexed citations
12.
Rada, Miran, Nickolai A. Barlev, & Salvador Macip. (2018). BTK modulates p73 activity to induce apoptosis independently of p53. Cell Death Discovery. 4(1). 30–30. 21 indexed citations
13.
Rada, Miran, et al.. (2018). Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer. Oncogene. 37(35). 4809–4820. 79 indexed citations
14.
Rada, Miran, Nickolai A. Barlev, & Salvador Macip. (2018). BTK: a two-faced effector in cancer and tumour suppression. Cell Death and Disease. 9(11). 1064–1064. 30 indexed citations
15.
Deng, Yanxiang, Megan E. Kizer, Miran Rada, et al.. (2018). Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell Hydroporator. Nano Letters. 18(4). 2705–2710. 76 indexed citations
16.
Rada, Miran, Jennifer Cha, Bo Zhou, et al.. (2018). Abstract A16: COL11A1 confers cisplatin resistance through fatty acid oxidation in ovarian cancer cells. Clinical Cancer Research. 24(15_Supplement). A16–A16. 2 indexed citations
17.
Rada, Miran, et al.. (2017). Abstract TMEM-017: COLLAGEN TYPE XI ALPHA 1 (COL11A1) IS A NOVEL STROMAL MEDIATOR OF CHEMORESISTANCE. Clinical Cancer Research. 23(11_Supplement). TMEM–17. 1 indexed citations
18.
Rada, Miran, Mohammad Althubiti, Koon-Guan Lee, et al.. (2017). BTK blocks the inhibitory effects of MDM2 on p53 activity. Oncotarget. 8(63). 106639–106647. 18 indexed citations
19.
Althubiti, Mohammad, Miran Rada, Koon-Guan Lee, et al.. (2016). BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses. Cancer Research. 76(18). 5405–5414. 48 indexed citations
20.
Rada, Miran, Е. А. Васильева, Larissa Lezina, et al.. (2016). Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 36(7). 922–932. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenny Paupert Breakdown of academic impact, for papers by Aaron M. LeBeau Breakdown of academic impact, for papers by Thale Kristin Olsen Breakdown of academic impact, for papers by Érika Cosset Breakdown of academic impact, for papers by Lele Zhang Breakdown of academic impact, for papers by Michael Faibish Breakdown of academic impact, for papers by Mark F. Santos Breakdown of academic impact, for papers by François Kuonen Breakdown of academic impact, for papers by Neel I. Nissen Breakdown of academic impact, for papers by Kiek Verrijp
Rankless by CCL
2026